Trip CBD Brand Soars to £200 Million Valuation
London's CBD drinks company Trip has achieved a remarkable valuation exceeding £200 million following a successful funding round that attracted high-profile backers including global superstar Joe Jonas. The husband-and-wife founding team of Daniel Khoury and Olivia Ferdi have seen their business become what they claim is the most valuable UK-founded drinks brand since household names Innocent and Fever-Tree emerged on the scene.
Celebrity Backing and Financial Growth
The recent investment round raised an impressive £30.3 million for the London-headquartered company, cementing its position in the competitive beverages market. Beyond Joe Jonas, the funding attracted support from an impressive roster of celebrities including model Alessandra Ambrosio, actor Paul Wesley, model Ashley Graham and internet personality Sophie Habboo.
Financial institutions also showed strong confidence in Trip's business model, with Coefficient Capital - previously known for backing oat milk giant Oatly - participating in the funding round. The company's financial performance demonstrates substantial growth, with revenue reaching £75.8 million this year and projections indicating this could double to over £151 million in the coming year.
Breaking Barriers in the Drinks Industry
Trip stands out not only for its financial achievements but also for its leadership structure. The company proudly states it has become the world's most valuable drinks company led by a female CEO and founder. Olivia Ferdi expressed her pride in the company's trajectory, stating: "We created Trip to make calm accessible to everyone, everywhere."
She emphasised that consumer and retailer response demonstrates "the world is ready for a new way to drink – one that prioritises balance and mental wellbeing." The company's mission-driven approach appears to resonate strongly in today's market, with Ferdi noting that Trip is "not just breaking records, but breaking barriers for female-founded and mission-driven businesses worldwide."
Regulatory Challenges and Future Outlook
The funding success comes despite recent regulatory challenges for the company. An advertisement for Trip was banned by the Advertising Standards Authority (ASA) for making unauthorised claims that the products could "help you feel calm" and reduce stress and anxiety. The ASA ruled these claims violated marketing regulations for food and drink ingredients.
At the time, Trip responded by removing the contentious claims while awaiting external advice, though the company expressed hope that it might be able to make such claims in the future. According to recently filed accounts, Trip had shareholder funds of £4.7 million as of February 2024, showing steady growth from £4 million in the previous year.
The company's latest financial results are scheduled for filing with Companies House by the end of February 2026, providing further insight into the financial health of this rapidly expanding CBD beverages brand.
